Biological and Pharmaceutical Bulletin · 2008 · 72 citations · 12 references
Life SciencesEndocrinologyPharmacologyMass Spectrometric AnalysisNeurochemistrySteroid BiochemistryNeuroprotectionSteroid Hormone BiochemistrySteroid MetabolismSteroid PharmacologySteroidogenesis RegulationStress Endocrinology5 Alpha-reductase5-Alpha-reductase Inhibition5-Alpha-reductase Inhibitor TherapyGamma-aminobutyric Acid Receptor ModulationImmobilizationNeurosteroid MetabolismNeurosteroid PharmacologyProgesterone Metabolism
In this study, we examined the influence of finasteride (FIN), a 5alpha-reductase inhibitor, on the brain levels and metabolism of neurosteroids [allopregnanolone (AP), 3alpha-dihydroprogesterone (3alpha-DHP), progesterone (PROG), 20alpha-dihydroprogesterone and 11-deoxycorticosterone (DOC)] in rats exposed to immobilization stress. For this purpose, the sensitive, reproducible and accurate liquid chromatography-electrospray ionization-tandem mass spectrometric (LC-ESI-MS/MS) methods that enable the quantification of trace amounts of brain neurosteroids were first developed. The animal study using these methods demonstrated that FIN dose-dependently inhibits the stress-induced elevation of the brain AP, a potent positive modulator of the gamma-aminobutyric acid (GABA) type A receptors, and a 10 mg/kg dose of FIN can almost completely deplete AP in the brains. The study also found that the 20alpha-reduction of PROG is enhanced when its 5alpha-reduction pathway is inhibited in the brains. No change was found in the brain levels of 3alpha-DHP, another GABAergic neurosteroid, and DOC by the administration of FIN.
12
R. H. Purdy, A. Leslie Morrow, James R. Blinn et al. · Journal of Medicinal Chemistry · 1990 · 297 citations
Monique Vallée, Jeffery D. Rivera, George F. Koob et al. · Analytical Biochemistry · 2000 · 174 citations
Medicine, Neuroscience, Pharmacology +13